By analyzing tissue from patients with Parkinson's disease, and animal and cellular models of the disease, a research team ...

Parkinson’s disease has long been defined by the slow, relentless loss of dopamine-producing neurons, with treatments focused ...

Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research ...

An international research team with strong participation from DTU has developed a new biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and ...

Immunotherapy that blocks microglial Fcγ receptors prevents dopaminergic neuron loss in Parkinson’s disease, revealing a potential new strategy.

Immunotherapy has transformed the field of medicine. In the context of cancer, immune cells become dysregulated and lose the ...

Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.

Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment strategy against heart disease. The antibody-based therapy could complement ...

By analyzing tissue from patients with Parkinson's disease, and animal and cellular models of the disease, a research team from the Institut de ...

Cancer immunotherapy has transformed modern oncology by harnessing body's own immune system to combat malignant disease.

Rainbow Children’s Heart Institute, Hyderabad, has reported one of the world’s first successful clinical cases of direct ...

By analyzing tissue from patients with Parkinson’s disease, and animal and cellular models of the disease, a research team from the Institut de Neurociències of the UAB has shown that the main immune ...